These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16098293)
21. Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review). Orditura M; Quaglia F; Morgillo F; Martinelli E; Lieto E; De Rosa G; Comunale D; Diadema MR; Ciardiello F; Catalano G; De Vita F Oncol Rep; 2004 Sep; 12(3):549-56. PubMed ID: 15289836 [TBL] [Abstract][Full Text] [Related]
22. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin. de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer. Stavridi F; Palmieri C Expert Rev Anticancer Ther; 2008 Dec; 8(12):1859-69. PubMed ID: 19046106 [TBL] [Abstract][Full Text] [Related]
24. Radionuclide evaluation of doxorubicin cardiotoxicity: the need for cautious interpretation. Dey HM; Kassamali H Clin Nucl Med; 1988 Aug; 13(8):565-8. PubMed ID: 3168370 [TBL] [Abstract][Full Text] [Related]
25. Echocardiographic evaluation of adriamycin cardiotoxicity in children. Ramos A; Meyer RA; Korfhagen J; Wong KY; Kaplan S Cancer Treat Rep; 1976 Sep; 60(9):1281-4. PubMed ID: 1016964 [TBL] [Abstract][Full Text] [Related]
26. High incidence of adriamycin cardiotoxicity in children even at low cumulative doses: role of radionuclide cardiac angiography. Agarwala S; Kumar R; Bhatnagar V; Bajpai M; Gupta DK; Mitra DK J Pediatr Surg; 2000 Dec; 35(12):1786-9. PubMed ID: 11101737 [TBL] [Abstract][Full Text] [Related]
27. Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial. Chia S; Clemons M; Martin LA; Rodgers A; Gelmon K; Pond GR; Panasci L J Clin Oncol; 2006 Jun; 24(18):2773-8. PubMed ID: 16682726 [TBL] [Abstract][Full Text] [Related]
28. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. Ewer MS; Vooletich MT; Durand JB; Woods ML; Davis JR; Valero V; Lenihan DJ J Clin Oncol; 2005 Nov; 23(31):7820-6. PubMed ID: 16258084 [TBL] [Abstract][Full Text] [Related]
29. Prediction of the left ventricular ejection fraction response to doxorubicin using a multiple linear regression model. Rabinovitch M; Suissa S; Stern J; Adam J; Mettauer B; Boileau G; Elstein J; Rouleau J Can J Cardiol; 1989; 5(8):382-8. PubMed ID: 2605548 [TBL] [Abstract][Full Text] [Related]
30. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy]. Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153 [TBL] [Abstract][Full Text] [Related]
31. Anticancer agents and cardiotoxicity. Ng R; Better N; Green MD Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642 [TBL] [Abstract][Full Text] [Related]
32. Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma. Limat S; Daguindau E; Cahn JY; Nerich V; Brion A; Perrin S; Woronoff-Lemsi MC; Deconinck E J Clin Pharm Ther; 2014 Apr; 39(2):168-74. PubMed ID: 24384030 [TBL] [Abstract][Full Text] [Related]
33. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy. Lunning MA; Kutty S; Rome ET; Li L; Padiyath A; Loberiza F; Bociek RG; Bierman PJ; Vose JM; Armitage JO; Porter TR Am J Clin Oncol; 2015 Aug; 38(4):377-81. PubMed ID: 24192805 [TBL] [Abstract][Full Text] [Related]
34. Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting. Saeed MF; Premecz S; Goyal V; Singal PK; Jassal DS Can J Physiol Pharmacol; 2014 Jul; 92(7):546-50. PubMed ID: 24959994 [TBL] [Abstract][Full Text] [Related]